Raymond James Trust’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $188K | Sell |
|
|||||
|
2024
Q2 | $176K | Buy |
|
|||||
|
2024
Q1 | $152K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $118K | Buy |
|
|||||
|
2022
Q4 | $117K | Hold |
|
|||||
|
2022
Q3 | $104K | Sell |
|
|||||
|
2022
Q2 | $214K | Sell |
|
|||||
|
2022
Q1 | $281K | Sell |
|
|||||
|
2021
Q4 | $276K | Sell |
|
|||||
|
2021
Q3 | $443K | Hold |
|
|||||
|
2021
Q2 | $450K | Sell |
|
|||||
|
2021
Q1 | $575K | Buy |
|
|||||
|
2020
Q4 | $457K | Sell |
|
|||||
|
2020
Q3 | $445K | Hold |
|
|||||
|
2020
Q2 | $608K | Buy |
|
|||||
|
2020
Q1 | $372K | Buy |
|
|||||
|
2019
Q4 | $343K | Sell |
|
|||||
|
2019
Q3 | $246K | Buy |
|
|||||
|
2019
Q2 | $326K | Buy |
|
|||||
|
2019
Q1 | $519K | Buy |
|
|||||
|
2018
Q4 | $509K | Buy |
|
|||||
|
2018
Q3 | $685K | Buy |
|
|||||
|
2018
Q2 | $771K | Buy |
|
|||||
|
2018
Q1 | $390K | Sell |
|
|||||
|
2017
Q4 | $492K | Sell |
|
|||||
|
2017
Q3 | $574K | Buy |
|
|||||
|
2017
Q2 | $813K | Buy |
|
|||||
|
2017
Q1 | $680K | Sell |
|
|||||
|
2016
Q4 | $871K | Sell |
|
|||||
|
2016
Q3 | $1.2M | Sell |
|
|||||
|
2016
Q2 | $1.34M | Sell |
|
|||||
|
2016
Q1 | $1.52M | Sell |
|
|||||
|
2015
Q4 | $1.9M | Sell |
|
|||||
|
2015
Q3 | $1.71M | Sell |
|
|||||
|
2015
Q2 | $1.93M | Buy |
|
|||||
|
2015
Q1 | $1.96M | Sell |
|
|||||
|
2014
Q4 | $1.83M | Buy |
|
|||||
|
2014
Q3 | $1.34M | Buy |
|
|||||
|
2014
Q2 | $1.23M | Buy |
|
|||||
|
2014
Q1 | $1.04M | Buy |
|
|||||
|
2013
Q4 | $452K | Buy |
|
|||||
|
2013
Q3 | $290K | Sell |
|
|||||
|
2013
Q2 | $315K | Buy |
|